Brings real-world examples to learning.
This comment is not public.
Gang Ruan is a Senior Associate Professor and Principal Investigator in the Academy of Pharmacy at Xi'an Jiaotong-Liverpool University. He earned his PhD from the National University of Singapore, followed by postdoctoral research at Emory University and a position as Research Scientist at The Ohio State University. From 2013 to 2021, he served as Professor in the College of Engineering and Applied Sciences at Nanjing University. Joining Xi'an Jiaotong-Liverpool University in 2022, he acted as Associate Dean for Research and Global Engagement at the Academy of Pharmacy from 2023 to 2025. He currently directs the Jiangsu Province Higher Education Key Laboratory of Cell Therapy Nanoformulation and the Suzhou Industrial Park Center of Excellence for Single-Molecule Single-Cell Imaging and Analysis. As co-founder of Core Quantum Technologies, a US-based company, he has translated nanobiomaterials technologies from laboratory research to commercial applications.
Professor Ruan leads an interdisciplinary team focused on nanomaterials-enabled technologies for biomedicine. His research encompasses precise assembly, manipulation, and analysis at the nanoscale; fundamental studies of biological delivery transport behaviors and related technology development; nanomaterials for cell therapies; and nanomaterials-mediated neural medicine technologies. He has produced 79 research outputs, including high-impact publications such as 'A nanoparticle-integrated complete manufacturing pipeline of chemically engineered exosomes' (Advanced Science, 2026), 'Protein−Polymer Coassembly Supraparticles as a Polyester-Based Drug Delivery Carrier with Ultrahigh Colloidal Stability and Drug Loading' (ACS Applied Materials & Interfaces, 2025), 'Engineered Extracellular Vesicles as a New Class of Nanomedicine' (2024), 'Scalable production of microscopic particles for biological delivery' (2023), and 'Mechanism-Driven Technology Development for Solving the Intracellular Delivery Problem of Hard-To-Transfect Cells' (Nano Letters, 2023). His inventions include one granted US patent and three granted Chinese invention patents on nanoparticle fabrication and applications. These contributions advance drug delivery systems, stem cell therapies, and regenerative medicine.

Photo by Osarugue Igbinoba on Unsplash
Have a story or a research paper to share? Become a contributor and publish your work on AcademicJobs.com.
Submit your Research - Make it Global News